Register now to R3i !
Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
The Initiative

Prof. Rody Sy

Prof. Rody Sy
University of Philippines,
Manila, Philippines
Current position
  Professor, Section of Cardiology, Department of Medicine, UP College of Medicine, Manilla, Philippines

Head, Cardiovascular Institute, Cardinal Santos Medical Center, San Juan, Philippines
Past position
1995 - 1998 Medical Director, Cardinal Santos Medical Center, San Juan, Philippines
1994 - 1999 Chief, Section of Cardiology, Department of Medicine, UP-PGH
1999 - 2000 Chairman, Specialty Board of Cardiology (Adult), Philippine College of Cardiology
Scientific training
1974 Doctor of Medicine, University of the Philippines
1974 - 1975 General Internship, UP-PGH Medical Center
1976 - 1979 Residency in Internal Medicine, UP-PGH Medical Center
1979 - 1982 Fellowship in Cardiology, Georgetown University Hospital, Washington, DC, USA
1983 Fellow and Diplomate, Philippine College of Physicians
1983 Fellow and Diplomate, Philippine College of Cardiology
1993 Fellow, American College of Cardiology
Professional Associations
2002 - 2006 President, Asian Pacific Society of Atherosclerosis and Vascular Diseases
1995 - 2002 President, Philippine Lipid Society
1991 - 1992 President, Philippine Heart Association
1993 - 2007 Trustee, Philippine Society of Hypertension
1996 Distinguished Fellow Award, Philippine College of Physicians
1998 Distinguished Service Award, Philippine Heart Association
1999 Distinguished Teacher Award, Philippine Heart Association
1999 Awardee, Most Distinguished Research in Cardiology, Philippine Heart Association,
Publications (selection)
  1. Sy RG, Punzalan FER for the PACER 2 Study Group. A multicenter, open label, 8 week study evaluating the efficacy and safety of once daily Atorvastatin in patients with hyperlipidemia. Phil J Int Med 2000; 38: 273-278.
  2. Wu CC, Sy RG, Tanphaichitr V, Tan ATT, Suyono S, Lee YT. Comparing the efficacy and safety of Atorvastatin and Simvastatin in Asians with elevated low density lipoprotein cholesterol – A multinational multicenter double blind study. J Formos Med Assoc 2002; 101: 478-487.
  3. Sy RG, Dans AL, Punzalan FER, Amarillo ML, Velandria F for the FNRI-HDL Study Group. The prevalence of dyslipidemia, diabetes, hypertension, stroke and angina pectoris in the Philippines. Phil J Int Med 2003; 41: 1-6.
  4. Litonjua A, Sy RG, Abarquez R, Lim-Abrahan MA, Asis L, Babilonia N, Bautista JA, Crisostomo M, Dizon E, Go RT, Mirasol R, Paz-Pacheco E, Palafox P, Pastores E, Quimpo J, Raboca J, Reyes E, Sapang BD, Sison MO, Sy RA, Uy Z, Villadolid M, Chua P, Aragon J for Philippine XENLO Study Group. Lipid lowering effect of Orlistat beyond weight reduction in overweight / obese Filipino patients: An RCT study. Phil J Int Med 2004; 42(6): 297-305.
  5. Punzalan FER, Sy RG, Ty-Willing T. Prevalence of metabolic syndrome among adult Filipinos. International Congress Series 1262(2004): 442-445.
  6. Punzalan FER, Sy RG, Santos RS, Cutiongco EM, Gosiengfiao S, Fadriguilan E, George P. Low Density Lipoprotein- Receptor (LDL-R) gene mutation among Filipinos with Familial Hypercholesterolemia. J Atheroscl Thromb 2005;12: 276-283.
  7. Sy RG, Cutiongco EM, Punzalan FER, Santos RS, Geronimo FRB, Tangco RV. Human Cholesteryl ester transfer protein (Taq1B) polymorphism among Filipinos with cardiovascular risk factors. J Atheroscl Thromb 2007; 14(3).
  8. Sy RG, Encabo R, Soria ML, et al. Prevalence of metabolic syndrome in young Filipino college students 18-25 years old. (final drafting and for submission for publication soon)
Research Interests
  • Metabolic Syndrome
  • Familial Hypercholesterolemia
  • Spearheaded the clinical arm in the 5th National Nutrition Survey 1998-99 with FNRI-DOST and DOH
Ongoing work
  • Philippine Cardiovascular Outcome Study (PhilCOS): An 8-year follow-up of the 1998 FNRI 5th NNS in the National Capital Region, Region 3 and Region 4. (Study will look at incidence of DM, prevalence of impaired fasting glucose, impaired glucose tolerance using standard oral glucose load. It will also look at predictability of Framingham CHD scoring system to Filipino subjects.)
  • Factors affecting HDL-C levels among Filipinos. (To correlate all potential factors in the 2003 NNHeS  survey affecting the low HDL-C level in the Philippines population.)